This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Compact view
Research pass: stub-manual Compound WATCH-LIST MEDIUM

4-AcO-DMT

Extended Research
Extended Research

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

Editor's verdict WATCH-LIST MEDIUM

Same plasticity + therapeutic profile as psilocybin (see [[psilocybin]]) — the prodrug differs only in absorption pharmacokinetics. The research-chem supply has occasional adulteration with stronger analogs (e.g., 4-AcO-DET) so identity verification matters. For Dylan at 20 with no depression indication, same WATCH-LIST verdict as psilocybin applies.

Research pass: stub-manual
Verdict change log
  • 2026-06-05 — Initial verdict WATCH-LIST, mirroring psilocybin. (stub)

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…